A randomised comparison of practice pharmacist-managed hypertension providing Level 3 Medication Review versus usual care in general practice

Journal of Applied Therapeutic Research

Volumn 7, Issue 3, 2010, Pages 77-86

  Jamieson, Lisa H ^a   Scally, Andy J ^b   Chrystyn, Henry ^c  

^a South West Surrey Area   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

Hypertension; Medication Review; Pharmacist

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; THYROXINE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; LOW DRUG DOSE; MALE; MANAGED CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACEUTICAL CARE; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 77958033468     PISSN: 10292659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Borenstein JE, Graber G, Saltiel E, Wallace J, Ryu S, Jackson A, Deutsch S, Weingarten SR. (2003) Physician-pharmacist comanagement of hypertension: A randomized, comparative trial. Pharmacotherapy 23:209-216.
2. Carter BL, Barnette DJ, Chrischilles E, Mazzotti GJ, Asali ZJ. (1997) Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy 17:1274-1285.
3. DOH. National service framework for elderly people. London: Department of Health, 2001.
4. Erickson SR, Slaughter R, Halapy H. (1997) Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy 17:140-147.
5. Franke RH, Kaul JD. (1978) The Hawthorne experiments: First statistical interpretation. American Sociological Review 48:623-643.
6. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S, for the HOT Study Group. (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351:1755-62. (Pubitemid 28269185)
7. Hawksworth GM, Chrystyn H. (1998) Domiciliary visits by a Community Pharmacist. Journal of Applied Therapeutics, 1:325-329.
8. Hepler CD, Strand LM. (1990) Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, 47:533-543.
9. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, Christou M, Evans D, Hand C. (2005) Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. British Medical Journal, 330:293-297.
10. Krska J, Cromaty JA, Arris F, Jamieson D, Hansford D, Duffus PRS, Downie G, Seymour DG. (2001) Pharmacist-led medication review in patienrts over 65: a randomized controlled trial in primary care. Age and Aging 30:205-211.
11. McMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. (1990) Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335:765-774.
12. Medicines Partnership and The National Collaborative Medicines Management Services Programme. Room for review: a guide to medication review. Medicines Partnership, London, 2002 http://www.npc.co.uk/med-partnership/assets/room-for- review.pdf
13. NICE Clinical Guideline 34: Hypertension. Management of hypertension in adults in primary care. June 2006. http://www.nice.org.uk/CG034.
14. Park JJ, Kelly P, Carter BL, Burgess PP. (1996) Comprehensive pharmaceutical care in the chain setting. Journal of the American Pharmacy Association 36:443-451.
15. Pharmaceutical Services Negotiating Committee (PSNC). The new NHS Community Pharmacy service - a summary of the structure. http://www.psnc.org.uk/ contract 2004
16. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. (1988) How common is white coat hypertension? Journal ofthe American Medical Association. 259:225-228.
17. The Community Pharmacy Medicines Management Project Evaluation Team. (2007) The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Family Practice. 24:189-200.
18. Thomas JM, Walker R. (2000) Impact of a practice pharmacist on patients taking antihypertensive medication. Pharmaceutical Journal 265 (Suppl): R5.
19. Vivian EM. (2002) Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 22:1533-1540.
20. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Server PS, Thom S McG. (2004) Guidelines for the management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 - BHS IV. Journal of Human Hypertension. 18:139-185. (Pubitemid 38425770)
21. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. (2001) Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. British Medical Journal 323:1-5.